Cargando…

Effects of variations in access to care for children with atopic dermatitis

BACKGROUND: An estimated 50% of children in the US are Medicaid-insured. Some of these patients have poor health literacy and limited access to medications and specialty care. These factors affect treatment utilization for pediatric patients with atopic dermatitis (AD), the most common inflammatory...

Descripción completa

Detalles Bibliográficos
Autores principales:	Siegfried, Elaine C., Paller, Amy S., Mina-Osorio, Paola, Vekeman, Francis, Kaur, Mandeep, Mallya, Usha G., Héroux, Julie, Miao, Raymond, Gadkari, Abhijit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749983/ https://www.ncbi.nlm.nih.gov/pubmed/33341118 http://dx.doi.org/10.1186/s12895-020-00114-x

Ejemplares similares

Real-world utilization patterns of systemic immunosuppressants among US adult patients with atopic dermatitis
por: Armstrong, April W., et al.
Publicado: (2019)

Validation of the Atopic Dermatitis Control Tool (ADCT©) using a longitudinal survey of biologic-treated patients with atopic dermatitis
por: Simpson, Eric, et al.
Publicado: (2019)

Clinically Meaningful Responses to Dupilumab in Adolescents with Uncontrolled Moderate-to-Severe Atopic Dermatitis: Post-hoc Analyses from a Randomized Clinical Trial
por: Paller, Amy S., et al.
Publicado: (2019)

A Systematic Scoping Literature Review of Publications Supporting Treatment Guidelines for Pediatric Atopic Dermatitis in Contrast to Clinical Practice Patterns
por: Siegfried, Elaine C., et al.
Publicado: (2018)

Conjunctivitis in Dupilumab Clinical Trials for Adolescents with Atopic Dermatitis or Asthma
por: Bansal, Ashish, et al.
Publicado: (2021)

Effect of Dupilumab on Laboratory Parameters in Adolescents with Atopic Dermatitis: Results from a Randomized, Placebo-Controlled, Phase 3 Clinical Trial
por: Siegfried, Elaine C., et al.
Publicado: (2021)

The Use of Real-World Data to Evaluate the Association Between Atopic Dermatitis and Cardiovascular Disease: A Retrospective Claims Analysis
por: Wu, Jashin J., et al.
Publicado: (2021)

Development, Psychometric Validation and Responder Definition of Worst Itch Scale in Children with Severe Atopic Dermatitis
por: Paller, Amy S., et al.
Publicado: (2022)

The microbiome in patients with atopic dermatitis
por: Paller, Amy S., et al.
Publicado: (2018)

The Posology of Dupilumab in Pediatric Patients With Atopic Dermatitis
por: Kamal, Mohamed A., et al.
Publicado: (2021)

Diagnosis of Atopic Dermatitis: Mimics, Overlaps, and Complications
por: Siegfried, Elaine C., et al.
Publicado: (2015)

Protocol for a prospective, observational, longitudinal study in paediatric patients with moderate-to-severe atopic dermatitis (PEDISTAD): study objectives, design and methodology
por: Paller, Amy S, et al.
Publicado: (2020)

Disease trajectories in childhood atopic dermatitis: an update and practitioner's guide
por: Irvine, A.D., et al.
Publicado: (2019)

The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA‐AD™): a clinical outcome measure for the severity of atopic dermatitis
por: Simpson, Eric L., et al.
Publicado: (2022)

Economic Evaluation of Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults
por: Kuznik, Andreas, et al.
Publicado: (2017)

Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis: A Phase 3 Randomized Clinical Trial
por: Simpson, Eric L., et al.
Publicado: (2019)

Burden of atopic dermatitis in Japanese adults: Analysis of data from the 2013 National Health and Wellness Survey
por: Arima, Kazuhiko, et al.
Publicado: (2018)

Infections in children and adolescents treated with dupilumab in pediatric clinical trials for atopic dermatitis—A pooled analysis of trial data
por: Paller, Amy S., et al.
Publicado: (2022)

Improvement in disease severity and pruritus outcomes with crisaborole ointment, 2%, by baseline atopic dermatitis severity in children and adolescents with mild‐to‐moderate atopic dermatitis
por: Eichenfield, Lawrence F., et al.
Publicado: (2020)

Pimecrolimus in atopic dermatitis: Consensus on safety and the need to allow use in infants
por: Luger, Thomas, et al.
Publicado: (2015)

Extent and consequences of inadequate disease control among adults with a history of moderate to severe atopic dermatitis
por: Wei, Wenhui, et al.
Publicado: (2017)

Positive Psychology Themes in Interviews of Children With Atopic Dermatitis: Qualitative Study
por: Lou, Terry M, et al.
Publicado: (2022)

Discordance Between Physician- and Patient-Reported Disease Severity in Adults with Atopic Dermatitis: A US Cross-Sectional Survey
por: Wei, Wenhui, et al.
Publicado: (2017)

Crisaborole Ointment Improves Quality of Life of Patients with Mild to Moderate Atopic Dermatitis and Their Families
por: Simpson, Eric L., et al.
Publicado: (2018)

Dupilumab Demonstrates Rapid and Consistent Improvement in Extent and Signs of Atopic Dermatitis Across All Anatomical Regions in Pediatric Patients 6 Years of Age and Older
por: Simpson, Eric L., et al.
Publicado: (2021)

Laboratory Safety from a Randomized 16-Week Phase III Study of Dupilumab in Children Aged 6 Months to 5 Years with Moderate-to-Severe Atopic Dermatitis
por: Paller, Amy S., et al.
Publicado: (2022)

Atopic dermatitis
por: Werfel, Thomas
Publicado: (2011)

Atopic dermatitis
por: Watson, Wade, et al.
Publicado: (2011)

Atopic dermatitis
por: Kapur, Sandeep, et al.
Publicado: (2018)

Atopic dermatitis
por: Galli, Elena, et al.
Publicado: (2020)

Is Dupilumab as Effective in Intrinsic Atopic Dermatitis as It Is in Extrinsic Atopic Dermatitis?
por: Gelato, Federica, et al.
Publicado: (2023)

Atopic dermatitis: allergic dermatitis or neuroimmune dermatitis?
por: Gaspar, Neide Kalil, et al.
Publicado: (2016)

IGAxBSA composite for assessing disease severity and response in patients with atopic dermatitis
por: Paller, A.S., et al.
Publicado: (2022)

Laboratory Safety of Dupilumab in Patients Aged 6–11 Years with Severe Atopic Dermatitis: Results from a Phase III Clinical Trial
por: Paller, Amy S., et al.
Publicado: (2021)

Real-World Effectiveness of Dupilumab in Atopic Dermatitis Patients: Analysis of an Electronic Medical Records Dataset
por: Eichenfield, Lawrence F., et al.
Publicado: (2022)

Tacrolimus ointment in the management of atopic dermatitis
por: Baldo, Antonello, et al.
Publicado: (2009)

A Critical Examination of Simulation Pricing and Access Recommendations for Atopic Dermatitis
por: Langley, Paul C.
Publicado: (2021)

Transcriptomic Analysis Links Eosinophilic Esophagitis and Atopic Dermatitis
por: Doucet-Ladevèze, Rémi, et al.
Publicado: (2019)

Atopic Dermatitis: Natural History, Diagnosis, and Treatment
por: Thomsen, Simon Francis
Publicado: (2014)

Qualitative Assessment of Adult Patients’ Perception of Atopic Dermatitis Using Natural Language Processing Analysis in a Cross-Sectional Study
por: Falissard, Bruno, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_f2qovge5vmlh067034r193ui6t